Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc V.VIV.H

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


TSXV:VIV.H - Post by User

Avivagen Inc > Avivagen Secures New Influential Customer in Mexico
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Ibuyvalueon Mar 08, 2022 11:18am
100 Views
Post# 34495366

RE:Avivagen Secures New Influential Customer in Mexico

RE:Avivagen Secures New Influential Customer in MexicoI think it's time for stone man to reveal his true identity he's been posting on this board insanity's for more than five years. the stewardship of Avivagen’s management is mediocre at best.
 
They've been promising that the dog treats would be a great success.
 they've been promising volumes of oxy beta to turn profitable for years .
 the only thing that has happened truly since Kim Anthony took the company's rain in February of 2017 is rounds of dilution, mediocre sales, overpaid management, Losses .
the stock went from a $1.25  to $0.20 today

so stone man you're an idiot.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities